[1]
|
R. Sheet, “History and Characterization of the Vero Cell Line, Technical Report,” Vaccines and Related Biological Products Advisory Committee, 2000.
|
[2]
|
K. Trabelsi, S. Rourou, H. Loukil, S. Majoul and H. Kalle, “Comparison of Various Culture Modes for the Production of Rabies Virus by Vero Cells Grown on Microcarriers in a 2L Bioreactor,” Enzyme and Microbial Technology, Vol. 36, No. 4, 2005, pp. 514-519.
|
[3]
|
S. Rourou, V. D. Ark, T. B. D. Velden and H. Kallel, “A Microcarrier Cell Culture Process for Propagating Rabies Virus in Vero Cells Grown in a Stirred Bioreactor under Fully Animal Component Free Conditions,” Vaccine, Vol. 25, No. 19, 2007, pp. 3879-3889.
|
[4]
|
O. Kistner, M. K. Howard, M. Spruth, W. Wodal, P. Bruhl, M. Gerencer, A. Brian, H. D. Crowe, I. Livey, M. Reiter, I. Mayerhofer, C. Tauer, L. Grillberger, W. Mundt, F. G. Falkner and N. P. Barrett, “Cell Culture (Vero) Derived Whole Virus (H5N1) Vaccine Based on Wild-Type Virus Strain Induces Cross-Protective Immune Respon- ses,” Vaccine, Vol. 25, No. 32, 2007, pp. 6028-6036.
|
[5]
|
H. Huang, X. Yi and Y. Zhang, “Improvement of Vero Cell Growth in Glutamate-Based Culture by Supplement- ing Ammoniagenic Compounds,” Process Biochemistry, Vol. 41, No. 12, 2006, pp. 2386-2392.
|
[6]
|
F. Horaud, “Absence of Viral Sequences in the WHO Vero Cell Bank: A Collaborative Study,” Development of Biological Standardization, Vol. 76, 1992, pp. 43-46.
|
[7]
|
M. Butler, “The Basics Animal Cell Culture and Tech- nology,” Oxford University Press, Oxford, 1996.
|
[8]
|
C. A. M. Groot, “Microcarrier Technology, Present Status and Perspective,” Cytotechnology, Vol. 18, No. 1-2, 1995, pp. 51-56.
|
[9]
|
H. Clark, K. Dai and K. Masashi, “The Design of Polymer Microcarrier Surfaces for Enhanced Cell Growth,” Biomaterials, Vol. 24, No. 23, 1999, pp. 4253-4264.
|
[10]
|
J. Malda and C. G. Frondoza, “Microcarriers in the Engineering of Cartilage and Bone,” Trends in Biotechnology, Vol. 24, No. 7, 2006, pp. 299-304.
|
[11]
|
A. J. Sinskey, R. J. Fleischaker and M. A. Tyo, “Production of Cell Derived Products: Virus and Interferon,” Annals of the New York Academy of Sciences, Vol. 369, No. 1, 1981, pp. 47-64.
|
[12]
|
L. A. White and E. W. Ades, “Growth of Vero E-6 Cells on Microcarriers in a Cell Bioreactor,” Journal of Clinical Microbiology, Vol. 28, No. 2, 1990, pp. 283-286.
|
[13]
|
B. L Seal, T. C. Otero and A. Panitch, “Polymeric Bio- materials for Tissue and Organ Regenaration,” Materials Science and Engineering, Vol. 34, No. 4, 2001, pp. 147- 230.
|
[14]
|
R. Freshney, “Culture of animal cells,” Wiley and Sons, Hoboken, 1998.
|
[15]
|
M. Saltzman and Kyriakides, “Principle of Tissue Engineering,” Elsevier Inc, Houston, 2007.
|
[16]
|
Solo Hill Engineering Inc, “Solohill Microcarrier Beads,” 2009. http://www.solohill.com/files/microcarrier_beads.pdf
|
[17]
|
S. C. Wu, C. C. Liu and W. C. Lianc, “Optimization of Microcarrier Cell Culture Process for the Inactivated Enterovirus Type 71 Vaccine Development,” Vaccine, Vol. 22, No. 29-30, 2004, pp. 3858-3864.
|
[18]
|
Y. Wang and F. Ouyang, “Recycle of Cyto-dex-3 in Vero Cell Culture,” Bioprocess Engineering, Vol. 21, No. 3, 1999, pp. 207-210.
|